logo

BACK(Delisted)

IMAC Holdings·NASDAQ
--
--(--)
Signals Analysis
Bullish signal 0
Bearish signal 1
EPS Below Expectations

Key Stats

0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000

About BACK

Imac Holdings, Inc.

A regenerative medicine company focused on developing and commercializing innovative biologics for musculoskeletal and other diseases

--
06/01/2018
02/13/2019
NASDAQ Stock Exchange
2
12-31
Common stock
3401 Mallory Lane, Suite 100, Franklin, Tennessee 37067
--
IMAC Holdings, Inc. was converted into a Delaware corporation on June 1, 2018 pursuant to a statutory merger. The company is a growing chain of integrated medicine and chiropractic (IMAC) regeneration centers that combines life science advancements with traditional healthcare for disease-limiting movements and conditions. IMAC Holdings, Inc., owns six and manages five outpatient clinics providing regenerative, plastic and minimally invasive surgery and treatment. The company's treatments are carried out by licensed physicians through its Regenerative Rehabilitation Program, which aims to improve physical health, improve quality of life and reduce patient suffering. Instead of prescribing opioids, the company offers an alternative to traditional surgery or joint replacement surgery, helping patients with sports injuries, back pain, knee pain, joint pain, ligament and tendon injuries, and other related soft tissue conditions by providing minimally invasive medical treatments.

Company Financials

EPS

BACK has released its 2023 Q3 earnings. EPS was reported at -2.63, versus the expected -0.6, missing expectations. The chart below visualizes how BACK has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

BACK has released its 2024 Q3 earnings report, with revenue of 56.30K, reflecting a YoY change of -96.40%, and net profit of -2.20M, showing a YoY change of 22.85%. The Sankey diagram below clearly presents BACK's revenue sources and cost distribution.

Forecast

Wall Street Opinions

Price Target

Volume Profile

Trade Flow Insight

Seasonals

Community Forum

Loading...

Related News

No articles available

Related Symbols

No Data

You can ask Aime

No Data